Pankaj Agarwal @pa_agarwal

TaRCoS: Target ID and Drug Repurposing Consultative Solution, https://t.co/k2Mjsa1Jex; Bioinformatics; https://t.co/tnbycWLKM4: Physician & Scientist Recruiting bioinfi.com King of Prussia, PA Joined February 2011

Tweets

117
Followers

164
Following

718
Likes

872

Pankaj Agarwal @pa_agarwal

3 years ago

Congratulations @kpfortney and the entire BioAge team. Tremendous validation of your AI-driven discovery platform and great news for patients.

BioAge @bioagelabs

3 years ago

Congratulations @kpfortney and the entire BioAge team. Tremendous validation of your AI-driven discovery platform and great news for patients.

1 4 27 0 1

Download Image

1 0 11 0 0

BioAge @bioagelabs

3 years ago

BioAge is thrilled to share positive topline data from our Phase 1b trial of BGE-105 for muscle atrophy. Our CEO @kpfortney on how these findings validate BioAge’s target discovery platform: News release: businesswire.com/news/home/2022…

1 4 27 0 1

Download Image

Pankaj Agarwal @pa_agarwal

3 years ago

Very nice. @OpenTargets Which download files capture these new annotations? @TRozday and @lesya_rzvvsk is there a paper or preprint describing these results?

Open Targets @OpenTargets

3 years ago

Very nice. @OpenTargets Which download files capture these new annotations? @TRozday and @lesya_rzvvsk is there a paper or preprint describing these results?

1 3 3 0 0

1 0 1 0 0

BioAge @bioagelabs

3 years ago

WEBINAR: The story of BioAge’s apelin receptor agonist BGE-105, from initial target identification through preclinical validation and clinical development. ➡️ Register (free!): physiology.org/detail/event/2… Wednesday, April 27, 1–2:15 PM EDT

2 10 16 0 1

Download Image

Nature Biotechnology @NatureBiotech

4 years ago

We continue to celebrate outstanding leaders in biotech for #WomensHistoryMonth. Today we recognize Kristen Fortney, co-founder and CEO of BioAge, which is developing a pipeline of therapies that target aging in order to increase healthspan and address chronic diseases

2 8 44 0 2

Download Image

Pankaj Agarwal @pa_agarwal

4 years ago

What are the implications of this on the massive effort in industry (& academia) on the variant to gene studies?

Yang Luo @yluo86

4 years ago

What are the implications of this on the massive effort in industry (& academia) on the variant to gene studies?

2 30 124 0 47

Download Image

0 1 0 0 0

Pankaj Agarwal @pa_agarwal

4 years ago

Wow! Congratulations.

Kristen Fortney @kpfortney

4 years ago

Wow! Congratulations.

1 4 36 0 2

0 0 1 0 0

Pankaj Agarwal @pa_agarwal

5 years ago

I thought baracitinib prediction and approval from @benevolent_ai was clearly informatics driven, @nicktatonetti .

Kirk Roberts @kirk_roberts

5 years ago

I thought baracitinib prediction and approval from @benevolent_ai was clearly informatics driven, @nicktatonetti .

1 3 7 0 0

Download Image

0 1 1 0 0

Pankaj Agarwal @pa_agarwal

5 years ago

Congratulations Chris and the Recursion team.

Endpoints News @endpts

5 years ago

Congratulations Chris and the Recursion team.

0 5 26 0 1

0 0 0 0 0

Endpoints News @endpts

5 years ago

The IPO market continues to churn, with a prominent AI drug developer becoming the latest biotech to register with the SEC. endpts.com/recursion-will…

0 5 26 0 1

Dr. John Whyte @drjohnwhyte

5 years ago

CDC just launched vaacinefinder. Need some improvements but another source of vaccine supply. Check it out. @CDCgov vaccinefinder.org

1 10 17 0 2

Kristen Fortney @kpfortney

5 years ago

BioAge’s first clinical trial EVER started today! So excited for this amazing milestone. Many more to come as we advance our mission to develop a pipeline of therapies that treat disease and extend healthspan.